Sitryx Therapeutics Makes Key Sppointments to Dtrengthen Business Operations and Progress Immunometabolism-Targeting Pipeline into Clinical Development March 5, 2024
TScan Therapeutics Presents Promising Updated Phase 1 Clinical Results on TSC-100 and TSC-101 February 26, 2024
KalVista Pharmaceuticals Reports Phase 3 Trial Meets All Endpoints for Sebetralstat as First Oral On-demand Therapy for Hereditary Angioedema February 23, 2024
